Position in BBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,992,841
+$2,845,022 QoQ
Shares Held
228,829
+23.7% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
5.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BOONE CAPITAL MANAGEMENT LLC holds $138,362,425 across 6 Biotechnology names. BBIO ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
421,236 | $38,913,781 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
500,522 | $37,584,196 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
547,871 | $30,949,232 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
This page
|
228,829 | $16,992,841 | |
| 5 | KOD |
Kodiak Sciences Inc.
|
281,332 | $10,724,375 | |
| 6 | TENX |
Tenax Therapeutics, Inc.
|
200,000 | $3,198,000 |
All Filings in BBIO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,992,841 | 228,829 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,147,819 | 184,963 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $23,907,047 | 460,282 | Shares | Sole | 2025-11-14 | |
| 2023-12-31 | $17,796,912 | 440,845 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,263,856 | 313,381 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||